INSP - Company ID 0001609550
The table below shows Inspire Medical Systems, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $204.58M | $224.50M | $217.09M | $201.32M | $203.19M | $195.88M |
| Cost of revenue | $27.67M | $31.77M | $34.67M | $30.71M | $32.40M | $29.84M |
| Gross profit | $176.91M | $192.73M | $182.41M | $170.61M | $170.79M | $166.04M |
| R&D | $25.83M | $24.21M | $26.21M | $27.80M | $26.08M | $28.86M |
Inspire Medical Systems, Inc. reported annual revenue of $911.98M for fiscal year 2025. That is up 13.6% from $802.80M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $16.43M (FY 2016) to $911.98M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $152.20M | $158.87M | $159.52M | $144.29M | $130.39M | $132.08M |
| Operating income | -$1.12M | $9.64M | -$3.32M | -$1.49M | $14.32M | $5.10M |
| Income tax | $13.69M | $3.62M | $1.26M | $1.17M | $1.83M | $1.05M |
| Net income | -$11.29M | $9.93M | -$3.59M | $2.99M | $18.50M | $9.79M |
| EPS (diluted) | -$0.39 | $0.34 | -$0.12 | $0.10 | $0.60 | $0.32 |